The FDA today approved Abilify MyCite, the first drug in the U.S. to have an ingestible sensor embedded within the pill that can track if the medication was taken.
The drug-device combination product is indicated for the treatment of schizophrenia, acute treatment of manic and mixed episodes linked with bipolar I disorder and as an add-on treatment for depression in adults.
Get the full story at our sister site, Drug Delivery Business News.
The post FDA approves first pill with sensor to track ingestion appeared first on MassDevice.